You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 18, May 13, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Men's Health
 •Prostate Disease
 •Oncology
 •Prostate Cancer
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Selenium and Vitamin E Supplementation for Cancer Prevention—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: SELECT found that selenium as L-selenomethionine at 200 µg per day did not decrease the risk of prostate cancer in a large randomized group of men whose baseline selenium distribution represents that of the US population. Secondary analyses of selenium supplementation effects by baseline selenium status in the much smaller NPC study (1312 participants vs 35 533 in SELECT) may help understand this outcome: a population of men who are replete in selenium will not benefit from selenium supplementation and may have an increased risk of diabetes.1

The design of SELECT does not address the contention of either Dr Rayman and colleagues or Drs Hurst and Fairweather-Tait regarding a potential benefit of selenium in men with low plasma levels of selenium. At present, the possibility that selenium may prevent prostate cancer in men with low plasma selenium levels is an unproved hypothesis that has not been tested as . . . [Full Text of this Article]

Scott M. Lippman, MD
slippman@mdanderson.org
University of Texas M. D. Anderson Cancer Center
Houston

Eric A. Klein, MD
Cleveland Clinic Lerner
Cleveland, Ohio

Phyllis J. Goodman, MS
Southwest Oncology Group Statistical Center
Seattle, Washington



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Randomized Trials of Antioxidant Supplementation for Cancer Prevention: First Bias, Now Chance—Next, Cause
Peter H. Gann
JAMA. 2009;301(1):102-103.
EXTRACT | FULL TEXT  

RELATED LETTERS

Selenium and Vitamin E Supplementation for Cancer Prevention
Margaret P. Rayman, Gerald F. Combs, Jr, and David J. Waters
JAMA. 2009;301(18):1876.
EXTRACT | FULL TEXT  

Selenium and Vitamin E Supplementation for Cancer Prevention
Rachel Hurst and Susan Fairweather-Tait
JAMA. 2009;301(18):1876-1877.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.